Overview of Japanese Generic Drug Market 2016: Recent Volume Share was 60.1% in the 2nd Quarter in 2016

Dublin, Oct. 20, 2016 -- Research and Markets has announced the addition of the "The Overview of Japanese Generic Drug Market" report to their offering.

This report talks about the overview of Japanese generic drug market.

The readers will understand overall climate surrounding generic market in Japan. The report covers related regulations, generics's share in Japan, market size, primary makers, market trend, and updated situation about biosimilars and authorized generics.

The share of generics in the prescription drugs market has been dramatically increasing in terms of both volume and value. The recent volume share was 60.1% in the 2nd quarter in 2016. This increase has been particularly pronounced since 2007 due to government measures devised to increase the use of generics.

Key Topics Covered:

1. Summary

2. Definition of Generic Drugs

3. Laws and Regulations Pertaining to Generics

4. NHI Drug Price

5. Share of Generics in Prescription Drugs Market

6. Market Size

7. Principal Industry Association

8. Sales of Major Japanese Generic Companies

9. Primary Generic Manufacturers

10. Overview of Leading Japanese Generics Companies

11. Current Market Environment Conditions

12. Considerations by Company Type

13. Government Measures to Promote the Use of Generics

14. Biosimilars

15. Authorized Generics

16. Future Outlook

Companies Mentioned

• Actavis
• Boehringer Ingelheim
• Daiichi Sankyo
• Hospira
• Lupin
• Meiji
• Mochida
• Mylan
• Nichi-Iko
• Nippon Chemiphar
• Nippon Kayaku,Kissei
• Ohara
• Sandoz
• Sanwa
• Sawai
• Teva
• Towa
• Zydus
  

For more information about this report visit http://www.researchandmarkets.com/research/fpctz5/the_overview_of

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Generic Drugs